After separatists in the southwestern Pakistani province of Balochistan claimed responsibility for a deadly bombing in the ...
It is very clear to us,’ Foreign office spokesperson Shafqat Ali Khan said while alleging that India is also running a ...
DM & DEO Hooghly held a meeting with all electoral registration officers on last Wednesday and also held district level ...
TECELRA® launch momentum accelerating – 10 patients apheresed in Q1 2025 and 3 in 2024; 20 ATCs available; all manufacturing and supply goals ...
Pak Journalist’s Big Claim: ‘Balochistan Liberation Army Targets Pakistan’s Nuclear Weapons’
The Balochistan Liberation Army (BLA) is eyeing the nuclear weapons of Pakistan after giving a jolt by hijacking the Jaffar Express which claimed several lives in the incident. The Pakistan Army and ...
The FDA has accepted the resubmitted BLA for linvoseltamab for patients with relapsed/refractory multiple myeloma.
1d
Zacks Investment Research on MSNFDA Accepts RDY & ALVO's Prolia & Xgeva Biosimilar BLA for ReviewDr. Reddy’s Laboratories RDY and partner, Alvotech ALVO, announced the FDA’s acceptance of a regulatory filing, seeking the ...
After two days of intense military operations, 33 attackers were killed, and 26 passengers — including 18 army and FC ...
INmune Bio's high-upside potential with CORDStrom for RDEB and XPro for Alzheimer's, offering up to 144.8x returns. Click ...
The table is a review of notable updates that occurred in February 2025 for investigational products in development.
Significant progress was made in 2024, including refining the Phase 3 program to accelerate rilparencel’s path to market in the U.S., the release ...
While data on functional endpoints are still to come, Avidity Biosciences Inc. executives said the firm is moving ahead with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results